<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00344799</url>
  </required_header>
  <id_info>
    <org_study_id>UCLA IRB#04-12-084</org_study_id>
    <nct_id>NCT00344799</nct_id>
  </id_info>
  <brief_title>Cytogenetic Study of Ocular Melanoma</brief_title>
  <official_title>Molecular and Cytogenetic Studies of Ocular Melanoma</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Jonsson Comprehensive Cancer Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Jonsson Comprehensive Cancer Center</source>
  <brief_summary>
    <textblock>
      Patients who are diagnosed with choroidal melanoma and undergo I-125 plaque or enucleation
      surgery consent to participate in the study. A tumor sample taken during surgery is studied
      in the lab for genetic features. These features and features of subjects' clinical course are
      recorded. Analysis of the data may identify genetic features that are indicative of
      prognostic factors including risk of metastasis.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The Jules Stein Eye Institute Ocular Melanoma Research Group is conducting cytogenetic
      studies of choroidal melanoma to improve the screening of biopsy samples of choroidal
      melanoma through cytogenetic analysis. Our goal is to identify molecular probes that
      specifically target regions of chromosomes that undergo changes characteristic of metastatic
      choroidal melanoma.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">January 8, 2005</start_date>
  <completion_date type="Anticipated">August 31, 2021</completion_date>
  <primary_completion_date type="Anticipated">August 31, 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <enrollment type="Anticipated">200</enrollment>
  <condition>Choroidal Melanoma</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Patients who have been diagnosed with ocular melanoma, and underwent melanoma treatment at
        our facility.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Patient with diagnosis of ocular melanoma

          2. Patient with local treatment plan for ocular melanoma- plaque brachytherapy or
             enucleation

          3. Patient 18 years of age or older

          4. Archival enucleation specimens with diagnosis of ocular melanoma

        Exclusion Criteria:

          1. Patient who refuses local melanoma treatment

          2. Patient who refuses to participate in this study
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Tara M McCannel, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Jules Stein Eye Institute, UCLA</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Bradley R Straatsma, MD, JD</last_name>
    <role>Study Director</role>
    <affiliation>Jules Stein Eye Institute, UCLA</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Lynn Gordon, MD, PhD</last_name>
    <role>Study Chair</role>
    <affiliation>Jules Stein Eye Institute, UCLA</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Ben Glasgow, MD</last_name>
    <role>Study Chair</role>
    <affiliation>Jules Stein Eye Institute, UCLA</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Nagesh P Rao, PhD</last_name>
    <role>Study Chair</role>
    <affiliation>UCLA Pathology and Laboratory Medicine</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Tara A McCannel, MD, PhD</last_name>
    <phone>310-206-7484</phone>
    <email>tmccannel@jsei.ucla.edu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Brenda Rangel</last_name>
    <phone>310 794-9962</phone>
    <email>Brangel@jsei.ucla.edu</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Jules Stein Eye Institute</name>
      <address>
        <city>Los Angeles</city>
        <state>California</state>
        <zip>90095</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Brenda Rangel</last_name>
      <phone>310-794-9962</phone>
      <email>Brangel@jsei.ucla.edu</email>
    </contact>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>September 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 26, 2006</study_first_submitted>
  <study_first_submitted_qc>June 26, 2006</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 27, 2006</study_first_posted>
  <last_update_submitted>September 12, 2017</last_update_submitted>
  <last_update_submitted_qc>September 12, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">September 13, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Choroidal Melanoma</keyword>
  <keyword>Choroidal Malignant Melanoma</keyword>
  <keyword>Ocular Melanoma</keyword>
  <keyword>Uveal Melanoma</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Melanoma</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

